code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Applies from E25 Adrenogenital disorders
Includes
adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
Female adrenal pseudohermaphroditism
Female heterosexual precocious pseudopuberty
Male isosexual precocious pseudopuberty
Male macrogenitosomia praecox
Male sexual precocity with adrenal hyperplasia
Male virilization (female)
Excludes1 (never code together)
indeterminate sex and pseudohermaphroditism (Q56)
chromosomal abnormalities (Q90-Q99)
Risk adjustment (HCC)
CMS-HCC V22: HCC 23 — Other Significant Endocrine and Metabolic Disorders
RxHCC V08: HCC 43 — Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders
ESRD V24: HCC 23
MS-DRG index
Defines the logic of DRG(s) 643-645 in MDC 10.
Approximate ICD-9-CM (GEMs)
255.2 Adrenogenital disorders (approximate)
Code annotations containing back-references to E25.8